Don't get your hopes up. They only enrolled the first 2-3 cohorts before halting enrollment.
I imagine they decided CheckVacc was superfluous. Or simply couldn't afford to develop it at the same time as the others.
Remember they had planned a trial very similar to the Vaxinia MAST trial, but using CheckVacc. But that got canned.
Don't get your hopes up. They only enrolled the first 2-3...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $394.1M | |||
| Open | High | Low | Value | Volume |
| 5.3¢ | 5.5¢ | 5.2¢ | $904.3K | 16.99M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 34 | 3963649 | 5.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.3¢ | 98999 | 1 |
View Market Depth
| Last trade - 16.10pm 11/09/2024 (20 minute delay) ? |
| IMU (ASX) Chart |